2-(3-methylazetidin-3-yl)oxy-N-(1-oxo-1-pyrrolidin-1-ylpropan-2-yl)acetamide

C13H23N3O3 — CID 102611541

IUPAC2-(3-methylazetidin-3-yl)oxy-N-(1-oxo-1-pyrrolidin-1-ylpropan-2-yl)acetamide
SMILESCC(NC(=O)COC1(C)CNC1)C(=O)N1CCCC1
InChIInChI=1S/C13H23N3O3/c1-10(12(18)16-5-3-4-6-16)15-11(17)7-19-13(2)8-14-9-13/h10,14H,3-9H2,1-2H3,(H,15,17)
InChIKeyHCGXJMSVPMLJBA-UHFFFAOYSA-N
MW269.34 g/mol
LogP-0.51
Rot. Bonds5

About 2-(3-methylazetidin-3-yl)oxy-N-(1-oxo-1-pyrrolidin-1-ylpropan-2-yl)acetamide

2-(3-methylazetidin-3-yl)oxy-N-(1-oxo-1-pyrrolidin-1-ylpropan-2-yl)acetamide (PubChem CID 102611541) has the molecular formula C13H23N3O3 and a molecular weight of 269.34 g/mol. Its IUPAC name is 2-(3-methylazetidin-3-yl)oxy-N-(1-oxo-1-pyrrolidin-1-ylpropan-2-yl)acetamide.

Molecular Properties

Compound Name2-(3-methylazetidin-3-yl)oxy-N-(1-oxo-1-pyrrolidin-1-ylpropan-2-yl)acetamide
PubChem CID102611541
Molecular FormulaC13H23N3O3
Molecular Weight269.34 g/mol
Exact Mass269.17
IUPAC Name2-(3-methylazetidin-3-yl)oxy-N-(1-oxo-1-pyrrolidin-1-ylpropan-2-yl)acetamide
SMILESCC(NC(=O)COC1(C)CNC1)C(=O)N1CCCC1
InChIInChI=1S/C13H23N3O3/c1-10(12(18)16-5-3-4-6-16)15-11(17)7-19-13(2)8-14-9-13/h10,14H,3-9H2,1-2H3,(H,15,17)
InChIKeyHCGXJMSVPMLJBA-UHFFFAOYSA-N
XLogP-0.51
TPSA70.67 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds5
Heavy Atoms19
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500269.34
LogP ≤ 5-0.51
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Analyze 2-(3-methylazetidin-3-yl)oxy-N-(1-oxo-1-pyrrolidin-1-ylpropan-2-yl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-amino-N-[(2S)-1-oxo-1-piperidin-1-ylpropan-2-yl]acetamide
CID 93360859
N-(1-oxo-1-pyrrolidin-1-ylpropan-2-yl)-2-(propylamino)acetamide
CID 113408453
N-(2,2-difluoroethyl)-2-(3-methylazetidin-3-yl)oxyacetamide
CID 102611604
2-(3-methylazetidin-3-yl)oxy-N-(1-methylcyclohexyl)acetamide
CID 102611433
N-[1-(dimethylamino)-4-methylpentan-2-yl]-2-(3-methylazetidin-3-yl)oxyacetamide
CID 102611874
N-(4-hydroxy-3-methylsulfanylbutan-2-yl)-2-(3-methylazetidin-3-yl)oxyacetamide
CID 106161497
N-(1-oxo-1-pyrrolidin-1-ylpropan-2-yl)-2-phenoxyacetamide
CID 47101035
2-(methylamino)-N-(1-oxo-1-piperidin-1-ylpropan-2-yl)acetamide
CID 60945403
N-(2,3-dimethylbutyl)-2-(3-methylazetidin-3-yl)oxyacetamide
CID 102611702
2-methyl-N-[2-[[2-(3-methylazetidin-3-yl)oxyacetyl]amino]ethyl]propanamide
CID 102610917
2-(3-methylazetidin-3-yl)oxyacetamide
CID 83065734
N-(1-hydroxypentan-3-yl)-2-(3-methylazetidin-3-yl)oxyacetamide
CID 102656606

Frequently Asked Questions

What is the IUPAC name of 2-(3-methylazetidin-3-yl)oxy-N-(1-oxo-1-pyrrolidin-1-ylpropan-2-yl)acetamide?
The IUPAC name of 2-(3-methylazetidin-3-yl)oxy-N-(1-oxo-1-pyrrolidin-1-ylpropan-2-yl)acetamide (CID 102611541) is 2-(3-methylazetidin-3-yl)oxy-N-(1-oxo-1-pyrrolidin-1-ylpropan-2-yl)acetamide.
What is the SMILES notation for 2-(3-methylazetidin-3-yl)oxy-N-(1-oxo-1-pyrrolidin-1-ylpropan-2-yl)acetamide?
The canonical SMILES for 2-(3-methylazetidin-3-yl)oxy-N-(1-oxo-1-pyrrolidin-1-ylpropan-2-yl)acetamide is CC(NC(=O)COC1(C)CNC1)C(=O)N1CCCC1.
What is the InChIKey of 2-(3-methylazetidin-3-yl)oxy-N-(1-oxo-1-pyrrolidin-1-ylpropan-2-yl)acetamide?
The InChIKey is HCGXJMSVPMLJBA-UHFFFAOYSA-N. The full InChI is InChI=1S/C13H23N3O3/c1-10(12(18)16-5-3-4-6-16)15-11(17)7-19-13(2)8-14-9-13/h10,14H,3-9H2,1-2H3,(H,15,17).
What are the key properties of 2-(3-methylazetidin-3-yl)oxy-N-(1-oxo-1-pyrrolidin-1-ylpropan-2-yl)acetamide?
2-(3-methylazetidin-3-yl)oxy-N-(1-oxo-1-pyrrolidin-1-ylpropan-2-yl)acetamide has a molecular weight of 269.34 g/mol, XLogP of -0.51, 5 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(3-methylazetidin-3-yl)oxy-N-(1-oxo-1-pyrrolidin-1-ylpropan-2-yl)acetamide is sourced from PubChem (CID 102611541), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).